PRODUCT DETAIL

Kaletra 200 mg/50 mg filmom obalené tablety

Code

80758

MA number

EU/1/01/172/007

Product Form:

tbl flm 360(3x120)x200 mg/50 mg (fľ.HDPE)

MA Status:

E - Valid centralised marketing authorisation

Type of procedure:

MAH, country:

AbbVie Deutschland GmbH & Co. KG, Germany

Therapeutic Class:

42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)

ATC:

J	ANTIINFECTIVES FOR SYSTEMIC USE
J05	ANTIVIRALS FOR SYSTEMIC USE
J05A	DIRECT ACTING ANTIVIRALS
J05AR	Antivirals for treatment of HIV infections, combinations
J05AR10	Lopinavir and Ritonavir

Shelf life:

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 8(3) application
MA issued:	20.03.2001
SmPC + PL:	European Medicines Agency's database
Safety feature	Yes
Data update:	07.03.2022